Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy?

Precigen Inc. (NASDAQ:PGEN) is one of the best healthcare penny stocks to buy according to hedge funds. On April 7, Precigen Inc. (NASDAQ:PGEN) reiterated its expectation that sales of its lead respiratory treatment, PAPZIMEOS, will exceed $18 million in the first quarter. It would be a significant increase, considering total sales for the candidate drug totaled $3.4 million in the fourth quarter of 2025.

Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy?

David Smart/Shutterstock.com

The significant sales increase would be driven by higher uptake, with patient hub enrollment having surpassed 300 patients in the fourth quarter. The US launch of the candidate drug continues to build strong momentum with a significant increase in the first quarter.

In addition, Precigen has received a significant boost from the Centers for Medicare & Medicaid Services, which assigned a permanent J-code J3404, to PAPZIMEOS. The designation is poised to streamline the claims process and facilitate broader patient access. In addition, the company has already filed a Marketing Authorization Application for the use of the treatment on adults with RRP with the European Medicines Agency.

Precigen Inc. (NASDAQ:PGEN) is a commercial-stage biopharmaceutical company focused on developing and commercializing next-generation gene and cell therapies, specifically in immuno-oncology, autoimmune disorders, and infectious diseases.

While we acknowledge the risk and potential of PGEN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PGEN and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 7 Penny Stocks That Aren’t Scams: Best Cheap Stocks to Buy and 8 Best Small-Cap Value Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.